Responsibility for overseeing operations and corporate business development. Operations are focused on establishing cutting-edge or best-in-class technologies in the Japanese pharmaceutical research market.

Management of Japanese operations and responsibility for business expansion in the Japanese market, engaging primarily with Japanese pharma companies.

In charge of corporate business development activities, focusing on new pharma research technologies. This included M&A projects, forming alliances with overseas companies for the Japanese market, and leading the establishment of new businesses in Japan.

A wide variety of responsibilities, including regulatory applications (US, EU and Japan), evaluation of in-licensing candidates, and was a key member of multiple projects to develop new bio-therapeutics. Also participated in small molecule therapeutic projects.

Lead researcher on a project to discover and validate novel oncology biomarkers. Much of the project utilized a human biomaterials-based approach.